Gene Express Lung Cancer Diagnostic Shows 96% Accuracy in Study
Gene Express Inc, Toledo, Ohio, says its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study.
Read MorePosted by Clinical Lab Products | Sep 27, 2007 | Cancer, Miscellaneous |
Gene Express Inc, Toledo, Ohio, says its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study.
Read MorePosted by Clinical Lab Products | Aug 18, 2006 | Cancer, Miscellaneous |
Researchers say they have developed a test that can predict with near certainty whether the most common form of lung cancer will return after surgery.
Read MorePosted by Alyx Arnett | Aug 8, 2025 | Lung Cancer |
A case study shows how the noninvasive test detected Stage 1A mucinous adenocarcinoma in a high-risk patient whose previous tests and follow-up scans had suggested a low probability of cancer.
Read MorePosted by Clinical Lab Products | Sep 13, 2012 | Cancer, Lung Cancer, Molecular Diagnostics, Unknown Origin & Other Cancer Types, Webcasts |
Barbara Chaitin, MD, will present the most updated practice guidelines in oncology from the National Cancer Center Network and discuss the pathologist’s role in molecular testing strategies, including EGFR, KRAS, and ALK testing in NSCLC, KRAS/BRAF testing in colorectal cancer, and screening for Lynch Syndrome in colon cancer specimens.
Read MorePosted by Chris Wolski | Jul 23, 2025 | Pancreatic |
Researchers have discovered how cellular stress and inflammation drive pancreatic cancer progression via the STAT3-ITGB3 pathway.
Read More